[Skip to Navigation]
Comment & Response
April 2016

Association of β-Blocker Treatment With Adverse Outcomes in Hypertensive Patients Undergoing Noncardiac Surgery—Reply

Author Affiliations
  • 1The Cardiovascular Research Center, Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark
  • 2Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California
  • 3Department of Medicine, Stanford University School of Medicine, Stanford, California
JAMA Intern Med. 2016;176(4):563-564. doi:10.1001/jamainternmed.2016.0285

In Reply We thank Dr Palatini for his interest in our study and agree that observational studies such as ours might be affected by unmeasured confounding factors, as we acknowledged in the article. Indeed, we made extensive efforts to exclude patients treated with β-blockers owing to cardiac or liver disease and further controlled statistically for a number of other potential confounding factors, using well-accepted techniques to minimize confounding. Despite all of these measures, some bias may persist due to imbalances in unmeasured factors, so the results should be interpreted accordingly.

Add or change institution